Zhao, Yi
Chen, Na-Ping
Su, Xian
Ma, Jia-Hui
Wang, Dong-Xin
Article History
Received: 14 August 2024
Accepted: 19 November 2024
First Online: 19 December 2024
Declarations
:
: This study was approved by the Biomedical Research Ethics Committee of Peking University First Hospital on October 27, 2022 (2022[470]). Ethical approval for the original study was provided by the Clinical Research Ethics Committee of Peking University First Hospital (Chairperson Prof Guo Xiaohui) and registered with the Chinese Clinical Trial Registry (ChiCTR-TRC-10000802). Participants or their legal representatives were provided informed consent prior to enrollment into the original study.
: Not applicable.
: The authors declare no competing interests.